Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126464023 | 12646402 | 3 | F | 20140911 | 20160901 | 20160812 | 20160922 | PER | US-ASTRAZENECA-2014SE69098 | ASTRAZENECA | 26496.00 | DY | F | Y | 93.00000 | KG | 20160922 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126464023 | 12646402 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | AAA0574,HB0051 | 22200 | 2 | MG | /wk | |||||||
| 126464023 | 12646402 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | TWICE DAILY | U | 0 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||||
| 126464023 | 12646402 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 126464023 | 12646402 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
| 126464023 | 12646402 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | TABLET | QID | |||||||
| 126464023 | 12646402 | 6 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126464023 | 12646402 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126464023 | 12646402 | 8 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 126464023 | 12646402 | 9 | C | ALEVE | NAPROXEN SODIUM | 1 | Oral | 220MG, DAILY, IF SHE WALKS TOO MUCH OR DOES TOO MUCH ACTIVITY SHE TAKES A SECOND DOSE OF ALEVE AT... | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126464023 | 12646402 | 1 | Type 2 diabetes mellitus |
| 126464023 | 12646402 | 2 | Type 2 diabetes mellitus |
| 126464023 | 12646402 | 3 | Gastrooesophageal reflux disease |
| 126464023 | 12646402 | 4 | Diabetes mellitus |
| 126464023 | 12646402 | 5 | Diabetes mellitus |
| 126464023 | 12646402 | 6 | Blood pressure abnormal |
| 126464023 | 12646402 | 7 | Blood cholesterol abnormal |
| 126464023 | 12646402 | 8 | Anticoagulant therapy |
| 126464023 | 12646402 | 9 | Arthritis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126464023 | 12646402 | Device malfunction | |
| 126464023 | 12646402 | Injection site haemorrhage | |
| 126464023 | 12646402 | Off label use | |
| 126464023 | 12646402 | Underdose | |
| 126464023 | 12646402 | Weight decreased | |
| 126464023 | 12646402 | Weight fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126464023 | 12646402 | 1 | 2012 | 0 | ||
| 126464023 | 12646402 | 2 | 2004 | 2012 | 0 | |
| 126464023 | 12646402 | 3 | 2004 | 0 |